Preoperative treatment with 5α-reductase inhibitors and the risk of hemorrhagic events in patients undergoing transurethral resection of the prostate – A population-based cohort study
CONCLUSIONS: This nationwide study did not show that significant associations exist between 5-alpha reductase inhibitor use before transurethral resection of the prostate and the risks of blood transfusion and blood clot evacuation or emergency visits for hematuria.
Source: Clinics - Category: General Medicine Source Type: research
More News: Blood Transusion | Databases & Libraries | Emergency Medicine | General Medicine | Health Insurance | Insurance | Statistics | Study | Taiwan Health